Abstract
In this issue of Blood, Stoddart et al think outside of the stem cell "box" to identify a therapeutically tractable pathway in del(5q) myelodysplastic syndrome (MDS), through blocking pathologically activated Wnt signaling arising within the stem cell niche.1
Cite
CITATION STYLE
APA
Lane, S. W., & Heidel, F. H. (2017, June 1). Hacking the stem cell niche. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-04-777789
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free